@FierceMedDev: ICYMI: Courtagen reels in $20M for genetic pediatric neurology disorder tests. Story | Follow @FierceMedDev
@EmilyWFierce: Boom in specialty pharma business draws questions from consumers, lawmakers and patient advocates. NYT story | Follow @EmilyWFierce
> A New Jersey court gave the greenlight for a whistleblower lawsuit from a former CMO at Johnson & Johnson ($JNJ) subsidiary Ethicon. He is accusing the company of firing him for raising safety concerns. More
> Private equity firm Arlington Capital Partners has acquired Avalign Technologies, which creates orthopedic and specialty surgical implants and instruments. Financial details remained undisclosed. More
> Fujifilm Medical Systems has submitted the first module toward its digital breast tomosynthesis PMA application, which is an upgrade for its Aspire Cristalle mammography system. It expects to complete the filing within the next year. More
> The FDA has cleared the Hemogrip Patch to treat uncontrolled hemorrhage at vascular access sites that bleed uncontrollably from University of Maryland spin-out company Remedium Technologies. More
Biotech News
@FierceBiotech: Biopharma's 10 highest-paid heads of R&D. Feature | Follow @FierceBiotech
@JohnCFierce: Chatted a bit with Immunocore's CEO, also chairman of MedCity, about global/UK #biotech $$$. Story | Follow @JohnCFierce
> Five Prime bets up to $452.5M on Inhibrx's cancer antibodies. More
> Playing defense, Baxalta makes its case for a new hemophilia drug. News
> Blazing biotech IPO market continues to deliver a fortune for startups. Story
Pharma News
@FiercePharma: FDA may tap $GOOG to beef up drug-safety monitoring. Story | Follow @FiercePharma
@EricPFierce: Gallant Pharma owner notified in jail by #FDA he is disbarred for life from the pharma industry. Item | Follow @EricPFierce
@CarlyHFierce: Dont you dare think for a second that I passed up the chance to discuss the $GSK wolf grandma on @FierceBiotech Radio. Listen | Follow @CarlyHFierce
>Endo whistleblower nabs $33.6M from feds for 'extraordinary' work in FCA suit. More
> Sanofi says sweeping management revamp won't come with job cuts. Story
Vaccines News
> GSK, bioCSL to increase flu vaccine deliveries to U.S. More
> Reuters: WHO, EMA likely to approve GlaxoSmithKline's malaria vaccine despite challenges. News
> GSK and J&J/Bavarian Nordic take Ebola candidates to Senegal, Europe. More
> Expect vaccines market to swell to $40B by 2020: Tufts CSDD. Article
> EMA to again place HPV vaccines under its safety lens. Story
CRO News
> Icon and Covance bet on diagnostics with a pair of cancer deals. More
> Aptuit scales up its production prowess for Phase III trials. News
> Frontage buys into biometrics with BDM deal. Report
> Under new ownership, Synexus expands across Europe. Story
> WuXi bets $50M on a new venture fund and eyes $200M more. Article
Pharma Manufacturing News
> GSK ramps up flu vax production after problems last year. News
> American Health Packaging pulls thousands of Wockhardt-made products from the market. Story
> Mylan issues third reminder that 'lifesaving' syringes are being recalled. More
> J&J expects Fort Washington, PA, consumer plant to be back on line soon. Story
> Pfizer announces it will shutter India plant, echoing same news from Sandoz. Article
Pharma Asia News
> India's biopharma woes grow with FDA Emcure plant ban. More
> Japan's Takeda files ixazomib NDA for relapsed multiple myeloma. Report
> WuXi Healthcare Ventures plucks $50M from WuXi PharmaTech as anchor for second fund. Article
> Price controls fail to improve poor people's access to medicines in India, IMS report says. Story
> CFDA eyes new Shanghai evaluation center to speed drug approvals. More